Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-050016

Co-Chief Executive Officer bought 2,000 shares at $2.60 ($5,198)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WEST MICHAEL D Co-Chief Executive Officer 2017-08-22 Purchase +2,000 $2.60 $5,198 882,864 D: show line 1 in the form
Open-market purchases · 2,000 sh · avg $2.60 · $5,198
Loading xslF345X03/doc4.xml…